BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2182045)

  • 1. Effect of prostaglandin E in multiple experimental models. VII. Effect on resistance to sepsis.
    Waymack JP; Guzman RF; Mason AD; Pruitt BA
    Burns; 1990 Feb; 16(1):9-12. PubMed ID: 2182045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostaglandin E in multiple experimental models. VI. Effect on T-cell subsets.
    Waymack JP; Guzman RF; Burleson DG; McManus AT; Mason AD; Pruitt BA
    Prostaglandins; 1989 Sep; 38(3):345-53. PubMed ID: 2528784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The degree of bacterial translocation is a determinant factor for mortality after burn injury and is improved by prostaglandin analogs.
    Fukushima R; Gianotti L; Alexander JW; Pyles T
    Ann Surg; 1992 Oct; 216(4):438-44; discussion 444-5. PubMed ID: 1417193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of prostaglandin E2 indomethacin & Ginkgo biloba extract on resistance to experimental sepsis.
    Cantürk NZ; Utkan NZ; Cantürk Z; Yenisey C; Yildirir C; Dülger M
    Indian J Med Res; 1998 Sep; 108():88-92. PubMed ID: 9798334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prostaglandin E in multiple experimental models. IV. Effect on resistance to endotoxin and tumor necrosis factor shock.
    Waymack JP; Moldawer LL; Lowry SF; Guzman RF; Okerberg CV; Mason AD; Pruitt BA
    J Surg Res; 1990 Oct; 49(4):328-32. PubMed ID: 2214741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prostaglandins in sepsis.
    Fletcher JR
    Scand J Infect Dis Suppl; 1982; 31():55-60. PubMed ID: 7048514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of mouse carcinoma in vivo with a prostaglandin E2 analogue and indomethacin.
    Bennett A; Carroll MA; Melhuish PB; Stamford IF
    Br J Cancer; 1985 Aug; 52(2):245-9. PubMed ID: 4027166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies.
    Li Y; Sun JF; Cui X; Mani H; Danner RL; Li X; Su JW; Fitz Y; Eichacker PQ
    Crit Care Med; 2011 May; 39(5):1104-12. PubMed ID: 21317646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel model to study neonatal Escherichia coli sepsis and the effect of treatment on the human immune system using humanized mice.
    Schlieckau F; Schulz D; Fill Malfertheiner S; Entleutner K; Seelbach-Goebel B; Ernst W
    Am J Reprod Immunol; 2018 Jul; 80(1):e12859. PubMed ID: 29672989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostaglandin E on immune function in multiple animal models.
    Waymack JP; Yurt RW
    Arch Surg; 1988 Nov; 123(11):1429-32. PubMed ID: 3263107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance.
    Gennari R; Alexander JW; Gianotti L; Eaves-Pyles T; Hartmann S
    Ann Surg; 1994 Jul; 220(1):68-76. PubMed ID: 8024361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rabbit model for ascending infection in pregnancy: intervention with indomethacin and delayed ampicillin-sulbactam therapy.
    Heddleston L; McDuffie RS; Gibbs RS
    Am J Obstet Gynecol; 1993 Sep; 169(3):708-12. PubMed ID: 8372884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostaglandin E in multiple experimental models: V. Effect on tumor/host interaction.
    Waymack JP; Chance WT
    J Surg Oncol; 1990 Oct; 45(2):110-6. PubMed ID: 1976854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of peritoneal carcinomatosis recurrence with a prostaglandin synthesis inhibitor, indomethacin].
    Narisawa T; Takahashi M; Masuda T; Nagasawa O; Koyama H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2496-501. PubMed ID: 3476022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of systemic antibodies against intestinal Escherichia coli in the prevention of bacterial translocation of Escherichia coli in a burn model in mice.
    Dijkstra HM; Apperloo-Renkema HZ; Manson WL; van der Waaij D; Klasen HJ
    J Trauma; 1994 Apr; 36(4):482-5. PubMed ID: 8158706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin improves survival in gram-negative sepsis.
    Short BL; Gardiner M; Walker RI; Jones SR; Fletcher JR
    Adv Shock Res; 1981; 6():27-36. PubMed ID: 6760707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of indomethacin on burn-induced immunosuppression.
    Latter DA; Tchervenkov JI; Nohr CW; Christou NV
    J Surg Res; 1987 Sep; 43(3):246-52. PubMed ID: 3626543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages.
    Ikegami R; Sugimoto Y; Segi E; Katsuyama M; Karahashi H; Amano F; Maruyama T; Yamane H; Tsuchiya S; Ichikawa A
    J Immunol; 2001 Apr; 166(7):4689-96. PubMed ID: 11254729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of antidiuretic hormone, indomethacin and naproxen on prostaglandin synthesis of experimentally infected and healthy kidneys.
    Túri S; Pulkkinen M; Kaihola HL; Kangas L; Nieminen L
    Int Urol Nephrol; 1982; 14(3):195-200. PubMed ID: 6761298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.